FIP is active in China supported by the FIP China Envoy Snr Col. Chen Zheng-Yu and through FIP’s membership organisation the Chinese Pharmaceutical Association.
Snr Col Chen works with the GuangDong Pharmaceutical Association, including on the development of Chinese pharmaceutical expert consensus statements, which are shared below.
Consensus statements on surgical pharmacy
In China, like in other countries of the world, pharmacy services are being transformed to meet clinical needs. At the end of 2015, the GuangDong Pharmaceutical Association (GDPA) in China proposed the concept of a “surgical pharmacist”. In September 2018, the GDPA appealed for the creation of surgical pharmacist positions in hospitals and defined their responsibilities as taking care of the whole process of medication management during the perioperative period and beyond. This involves focusing on perioperative medicines, such as anti-infection, anti-thrombosis and analgesia medicines, as well as on clinical nutrition, blood glucose, blood pressure, liquids management, the treatment of postoperative nausea and vomiting, the use of glucocorticoids, controlled drugs management, medicines reconciliation and deprescribing. A further responsibility is the management of drugs prone to be used irrationally, such as proton pump inhibitors, as well as medicines used beyond the perioperative period but related to the procedures, such as immunosuppressants for transplantation patients. The following consensus statements are availalble:
- Blood pressure management in the perioperative period by medical and pharmaceutical experts
- Clinical pharmacists’ pharmaceutical care for postoperative pain in Guangdong Province
- Guidelines for full-process pharmaceutical care for subcutaneous preparations of antitumor drugs
- Guidelines on integrated surgical pharmaceutical managements for immune checkpoint inhibitor therapy in malignancy
- Home pharmaceutical therapy management for colorectal cancer
- Long-term management of immunosuppressants in Chinese renal transplant recipients
- Management of non-blood haemostatic drugs during perioperative period
- Nuclear pharmacist management and clinical use of radiopharmaceuticals
- Perioperative medication therapy management within enhanced recovery after surgery programmes
- Physician-pharmacist co-management of perioperative airway
- Physician-pharmacist co-management of perioperative blood glucose
- Precision medicine by surgical pharmacists for oncology in the perioperative period
- Surgical pharmacy practice of parenteral and enteral nutrition
In an article for the IPJ in January 2023, Zheng Zhi-hua, founder of surgical pharmacy, vice president and general secretary of GuangDong Pharmaceutical Association, China, and Chen Zheng-yu, FIP China envoy, describe the development of surgical pharmacy as a new specialty whose practitioners can act as a bridge between surgeons and physicians. Read the article here.
The GDPA’s Surgical Pharmacy training course has been awarded the FIP Seal. It equips pharmacists with the knowledge and skills needed for effective medication management for surgical settings, integrating pharmaceutical expertise to improve patient outcomes. The course is designed for pharmacists, educators, students and other healthcare professionals in surgical care, and aims to enhance their proficiency in surgical medicines and clarify pharmacists’ roles in surgical contexts. For pharmacists based in China, learn more and enrol here.
|
The growing global importance of surgical pharmacy was highlighted by FIP president Paul Sinclair during an interview with China Medical Tribune at the event "Pharmacy Breaking Through: Building a Global Ecosystem Together", held in Hangzhou in April. He noted that, due to the unique pathophysiological needs of surgical patients, Surgical Pharmacy has developed into a distinct and well-established specialty. He also recognised Professor Zhi-hua Zheng, founder of Surgical Pharmacy, for driving a significant advancement in pharmacy practice in China by positioning surgical pharmacists as integral members of the surgical team, working alongside surgeons and anaesthesiologists. Referring to the FIP Seal-awarded surgical pharmacy training programme, Col Zheng-Yu Chen, FIP China Envoy, added that global partners will deepen collaboration to promote the Chinese model and help build a safer and more efficient pharmaceutical care ecosystem for patients. |
|
Other consensus statements
- Antibiotic prophylaxis for pregnant women during peripartum period
- Drug-drug interactions management of poly ADP-ribose polymerase inhibitors
- Information audit of outpatient and emergency prescriptions in healthcare institutions
- Medication safety in polypharmacy in patients with type 2 diabetes and chronic kidney disease
- Pharmaceutical Care for Anti-Tumor Drugs Taxanes
- Physician-pharmacist collaborative management of stable chronic obstructive pulmonary disease
- Prescription review rules of anticoagulant drugs
- Rapid clinical evaluation of angiotensin-converting enzyme inhibitors
- Rational use for inhaled medicines administrated by nebulizers
- Standard management for doping-containing medicines in medical institutions
- The application of nanopore sequencing in the detection of pathogenic microorganisms
- Whole-process pharmaceutical care for iodine contrast media
FIP resources in Chinese
- Early life nutrition: Supporting parents and caregivers in community pharmacy practice (with Chinese subtitles)
- Cardiovascular diseases: A handbook for pharmacists
- FIP knowledge and skills reference guide for professional development in cardiovascular diseases
- Cancer: A handbook for pharmacists
- FIP knowledge and skills reference guide for professional development in cancer care
- Supporting tobacco cessation and the treatment of tobacco dependence: A handbook for pharmacists
- Chronic respiratory diseases: A handbook for pharmacists
- Knowledge and skills reference guide for professional development in chronic respiratory diseases: A companion to the FIP chronic respiratory diseases handbook for pharmacists
- Chronic respiratory diseases: A handbook for pharmacists
- Knowledge and skills reference guide for professional development in chronic respiratory diseases: A companion to the FIP chronic respiratory diseases handbook for pharmacists
- Diabetes prevention, screening and management: A handbook for pharmacists
- Knowledge and skills reference guide for professional development in diabetes
- Mental health care: A handbook for pharmacists
- Knowledge and skills reference guide for professional development in mental health care
- FIP Call to action on “Mobilising pharmacists in our communities to mitigate the impact of air pollution on health”